Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 201
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?
The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science
Megan Bowers & Mikayla Hellwich: MDMA History, Harm Reduction, and the Problem With Prohibition
Pα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly; Turnbull Doubles Down on BOL-148; Compass Talks Indication Expansion, Could VA Help?
From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT
Psychedelic Bulletin: Tracking LSD Patents; Psilocybin Effective for a Year in...
PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic...
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...
HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S....
Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent
COMPASS Pathways plc to announce fourth quarter and full year 2021...
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...
Awakn Files Patent For A New Class Of Entactogen-Like Molecules
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study
PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation
Load more